Resona Asset Management Co.,Ltd. Krystal Biotech, Inc. Call Options Transaction History
Resona Asset Management Co.,Ltd.
- $20.6 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KRYS
# of Institutions
314Shares Held
24.7MCall Options Held
418KPut Options Held
485K-
Black Rock Inc. New York, NY3.95MShares$781 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$559 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.66MShares$526 Million6.67% of portfolio
-
State Street Corp Boston, MA1.36MShares$268 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA942KShares$186 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.08B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...